New Product Development
As per FMI – an ESOMAR-certified market research firm, the global patient lateral transfer market is expected to reach US$ 519.3 Mn by 2030. The likelihood of patients moving and getting lifted from stretchers or bed causing back injuries, strain to caregivers and healthcare workers owing to forceful exertion, repetitive movement, and awkward posture can’t be ruled out. …
Continue reading “Patient Lateral Transfer Market is expected to reach US$ 519.3 Million by 2030”
Biologics are genetically engineered proteins which originate from human genes. These drugs target the specific parts of the immune system. Biologics are entirely different from chemically synthesized drugs. There is wide range of biologics products include vaccines, blood components, allergenic, somatic cells, gene therapy and recombinant therapeutic proteins. Biologics are constituted as nucleic acids or …
A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be benign or malignant. Brain tumor arises from brain tissue and rarely spreads. The tumor eventually compress and damage other structures in the brain. According to American Brain Tumor Association (ABTA), there are two types of brain tumors – …
Hypothermia is a condition when the body temperature drops due to prolonged exposure to cold temperatures. The average body temperature is about 98.6 degrees Fahrenheit, basically with hypothermia the temperature drops below 95 degrees Fahrenheit. Hypothermia usually occurs due to the steadiness between the body’s heat generation and heat loss proceed for heat loss for …
Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The new advanced technologies has qualified …
Vascular access systems are intended for a series of diagnostic tests and treatments such as central venous pressure readings, blood sampling, fluid infusion, blood transfusion, parenteral and drugs administration such as chemotherapeutic agents, analgesics, antibiotics. Vascular access systems can be defined as the material which is implanted subcutaneously in a region over the upper chest …
Global pharmaceutical lipids market is projected to rise at a considerable pace between 2021 and 2031, finds Future Market Insights in an in-depth study. Growth registered in the market is attributable to increasing cases of cholesterol abnormalities and lipid associated disorders. Lipids are generally utilized in industries such as cosmetics and personal care, beverage and food, and …
Glioblastoma Treatment Drugs Market: Drivers & Restraints Glioblastoma is a complicated disease and thus the treatment for it involves various approaches combining various treatments which is the major market driver for Glioblastoma treatment drugs market. Treating such tumors is a challenge which forces the researchers to look for diagnosis and newer chemotherapy drugs. Changing demography, …
The USD 3 billion compression therapy market is likely to grow witness 6% CAGR through 2030, despite the COVID-19 blip, according to market research firm Future Market Insights. According to a latest study that tracks compression therapy adoption and market analysis in 20+ countries, the long-term outlook remains optimistic. Highlighting the key influencing factors, the study opines that …
Continue reading “Compression Therapy Market is expected to witness a CAGR of 6 % through 2030”
The medical cannula market is likely to reach US$ 784 million by 2030, according to a latest report by ESOMAR-certified firm, Future Market Insights. The report offers detailed insights on the medical cannula landscape, charting the key influencing factors in 20+ countries. A comprehensive profiling of the leading players in the medical cannula market is also included in …
Continue reading “Medical Cannula Market is likely to reach US$ 784 million by 2030”